Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma.
Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma.
复制标题
DOI:
10.4049/jimmunol.1000630
复制
发表时间:
2010-11-01
期刊:
影响因子:
--
通讯作者:
Bishop GA
中科院分区:
文献类型:
--
作者:
Munroe ME;Businga TR;Kline JN;Bishop GA
Chronic airway inflammation is a hallmark of asthma, an immune-based disease with great societal impact. Honokiol (HNK), a phenolic neurotransmitter receptor (GABAA) agonist purified from magnolia, has anti-inflammatory properties, including stabilization of inflammation in experimentally-induced arthritis. The present study tested the prediction that HNK could inhibit the chronic inflammatory component of allergic asthma. C57Bl/6 mice sensitized to and challenged with ovalbumin (OVA) had increased airway hyperresponsiveness to methacholine challenge and eosinophilia compared to naïve controls. HNK-treated mice showed a reduction in airway hyperresponsiveness as well as a significant decrease in lung eosinophilia. Histopathology studies revealed a marked drop in lung inflammation, goblet cell hyperplasia, and collagen deposition with HNK treatment. Antigen recall responses from HNK-treated mice showed decreased pro-inflammatory cytokines in response to OVA, including TNF-α, IL-6, Th1, and Th17-type cytokines, despite an increase in Th2-type cytokines. Regulatory cytokines IL-10 and TGF-β were also increased. Assessment of lung homogenates revealed a similar pattern of cytokines, with a noted increase in the number of FoxP3+ cells in the lung. HNK was able to alter B- and T-lymphocyte cytokine secretion in a GABAA dependent manner. These results indicate that symptoms and pathology of asthma can be alleviated even in the presence of increased Th2 cytokines, and that neurotransmitter agonists such as HNK have promise as a novel class of antiinflammatory agents in the treatment of chronic asthma.
登录
查看更多内容
DOI:
10.1084/jem.193.8.943
发表时间:
2001-04-16
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Brown KD;Hostager BS;Bishop GA
通讯作者:
Bishop GA
影响因子:
3.1
作者:
Ai, JL;Wang, XM;Nielsen, M
通讯作者:
Nielsen, M
影响因子:
4.8
作者:
Chen, Y;Thai, P;Wu, R
通讯作者:
Wu, R
影响因子:
5.4
作者:
BISHOP, GA;WARREN, WD;BERTON, MT
通讯作者:
BERTON, MT
影响因子:
5.8
作者:
Durairaj, L;Launspach, J;Zabner, J
通讯作者:
Zabner, J